SCHEMBL24638041

SCHEMBL24638041

CC/C(=C/C(C)(CC)CC)c1ccc(N)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 4/20 0.43
▸ ESR1 P03372 3/20 0.39
▸ ESR2 Q92731 3/20 0.39
▸ LMNA P02545 2/20 0.37
▸ CYP1A2 P05177 2/20 0.37
▸ CYP3A4 P08684 2/20 0.37
▸ MAOA P21397 1/20 0.37
▸ NPC1 O15118 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ RAB9A P51151 2/20 0.35
▸ EPHX2 P34913 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ PDE4D Q08499 1/20 0.33
▸ PRKCI P41743 1/20 0.33
▸ MASP2 O00187 1/20 0.32
▸ PLAU P00749 1/20 0.32
▸ THPO P40225 1/20 0.32
▸ ESRRG P62508 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28201867 0.73 CYP19A1 (0.48) CYP19A1ESR1ESR2LMNACYP1A2
SCHEMBL9321897 0.72 ESR1 (0.69) CYP19A1ESR1ESR2LMNACYP1A2
SCHEMBL9321894 0.72 ESR1 (0.69) CYP19A1ESR1ESR2LMNACYP1A2
SCHEMBL10638510 0.69 LMNA (0.46) CYP19A1ESR1ESR2LMNACYP1A2
SCHEMBL1178330 0.69 LMNA (0.46) CYP19A1ESR1ESR2LMNACYP1A2
SCHEMBL3264307 0.65 CYP19A1 (0.58) CYP19A1ESR1ESR2LMNACYP1A2
SCHEMBL19257842 0.65 MAPK1 (0.41) LMNANPC1MAPTRAB9AALDH1A1
SCHEMBL19400486 0.64 LMNA (0.48) CYP19A1ESR1ESR2LMNACYP1A2
SCHEMBL27470926 0.63 CYP19A1 (0.56) CYP19A1ESR1ESR2LMNACYP1A2
SCHEMBL7173100 0.63 ATM (0.36) ESR1ESR2CYP1A2CYP2C19ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3500252-B1 MODIFIED PEPTIDES FOR USE IN TREATING NEURODEGENERATIVE DISORDERS NEURO BIO LTD (GB) 2022-11-02 — — EP disclosed
Send feedback